Rachel K. King

Rachel K. King

Dir., President and Chief Executive Officer at GlycoMimetics, Inc.

Are you Rachel K. King? Claim your profile
 
  • IDENTIFY corporate executives in Rachel K. King's network and community.
  • FOLLOW changes in Rachel K. King's employment and money-in-motion.
  • CONNECT with Rachel K. King through your network of contacts.

Rachel K. King's Executive Work History


Current
Dir., President and Chief Executive Officer, GlycoMimetics, Inc.
Past
To view Rachel K. King's complete executive work history,
Age
57
 
 

Rachel K. King's Biography


Ms. King is a co-founder of our company and has served as our President and Chief Executive Officer and as a member of our Board since our inception in 2003. Previously, Ms. King was an Executive in Residence at NEA from 2001 to 2003. From 1999 to 2001, Ms. King served as a Senior Vice President of Novartis Corporation, a pharmaceutical company. Before joining Novartis, Ms. King spent 10 years with Genetic Therapy, Inc., a biotechnology company, where she served in a number of roles as part of the executive team, which included the company's initial public offering and later acquisition by Novartis. After the acquisition by Novartis, she serv ...

(Read More)

Source: GlycoMimetics, Inc. on 04/20/2017

 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Rachel K. King. More specifically, you'll be able to:

  • IDENTIFY corporate executives in Rachel K. King's network and community.
  • FOLLOW changes in Rachel K. King's employment and money-in-motion.
  • CONNECT with Rachel K. King through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: Rachel K. King

Rachel K. King's Connections (135)


Chairman of the Board, Chief Executive Officer and President, OncoMed Pharmaceuticals, Inc.
Executive Vice President and Chief Commercial Officer, Vertex Pharmaceuticals Incorporated
Dir., President and Chief Executive Officer, Conatus Pharmaceuticals Inc.
Chief Business Development Officer, Acorda Therapeutics, Inc.
Chairman of the Board, Acceleron Pharma Inc.
Chairman of the Board and Chief Executive Officer, Amicus Therapeutics, Inc.